Impact of Capillary Leak and Hypoalbuminemia on PK/PD of Anidulafungin and Caspofungin in Critically Ill Patients

ConditionCritically Ill Patients

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorUniversitaire Ziekenhuizen KU Leuven

About this trial

This prospective study will explore the pharmacokinetic exposure and pharmacodynamics of the echinocandins (caspofungin or anidulafungin) in critically ill patients.

Eligibility criteria

Qualifiers

Treatment with anidulafungin or caspofungin

Admitted to an ICU ward

Disqualifiers

< 18 years

DNR 2 or 3

Trial design

Treatments tested in this trial

Sample collection

Treatment groups

No treatment groups listed

Sponsors and collaborators

Universitaire Ziekenhuizen KU Leuven

Lead sponsor

KU Leuven

Collaborator

Source ClinicalTrials.gov